Vitamin C (CAS 50-81-7): Anticancer Mechanisms and Benchmark Evidence

Executive Summary: Vitamin C (ascorbic acid, C6H8O6) is a water-soluble vitamin with a molecular weight of 176.12 and is supplied as a high-purity solid by APExBIO (≥98%) (product page). It demonstrates robust antiproliferative effects, inhibiting tumor cell growth and inducing apoptosis in murine CT26 colon cancer cells at concentrations between 100–1000 μg/mL (cell culture, 37°C, pH 7.4) [DOI]. In vivo, Vitamin C has been shown to significantly reduce tumor volume in both CT26 and 4T1 tumor-bearing BALB/c mouse models. It has emerging antiviral relevance, including applications in hepatitis E virus (HEV) organoid systems. Vitamin C is easily dissolved in water (≥57.9 mg/mL), ethanol (≥12.2 mg/mL, ultrasound), and DMSO (≥5.8 mg/mL), but solutions should be used promptly to preserve stability. All claims are grounded in peer-reviewed sources and supplier-validated data.

Biological Rationale

Vitamin C, also referred to as ascorbic acid, is essential for mammalian physiology and acts as a key antioxidant by scavenging reactive oxygen species (ROS). Its role as an anticancer agent is supported by its ability to modulate oxidative stress, regulate cell cycle checkpoints, and enhance cellular apoptosis. Vitamin C participates in the biosynthesis of collagen, neurotransmitters, and carnitine, and assists in iron absorption (product page). Its water solubility ensures rapid bioavailability and cellular uptake in most experimental systems. The compound’s relevance in cancer biology stems from its dual capacity as an antioxidant and pro-oxidant, depending on the dose and cellular context (see comparative review). This article extends prior reviews by providing new evidence from recent organoid models.

Mechanism of Action of Vitamin C (CAS 50-81-7)

Vitamin C inhibits tumor cell proliferation and induces apoptosis through several well-characterized pathways:

• Antioxidant Activity: At physiological concentrations, Vitamin C acts as a ROS scavenger, protecting cells from oxidative DNA damage.
• Pro-oxidant Effects: At pharmacologic doses, particularly in the presence of transition metals, Vitamin C can generate hydrogen peroxide, which selectively induces cytotoxicity in tumor cells.
• Cell Cycle Arrest: Vitamin C modulates cell cycle regulatory proteins (e.g., p21, p53), resulting in G0/G1 or S-phase arrest.
• Induction of Apoptosis: Dose-dependent activation of caspases and disruption of mitochondrial membrane potential are observed in cancer cell lines exposed to 200–1000 μg/mL Vitamin C (24–48 h, 37°C, standard DMEM).
• Epigenetic Modulation: Vitamin C acts as a cofactor for dioxygenases involved in DNA and histone demethylation, leading to reactivation of tumor suppressor genes.

Evidence & Benchmarks

• Vitamin C inhibits proliferation of CT26 murine colon cancer cells at 100–200 μg/mL (cell culture, 37°C, 5% CO₂), with dose-dependent effects up to 1000 μg/mL (Liu et al., 2025).
• Apoptosis is induced in CT26 cells at concentrations of 200–1000 μg/mL, as measured by flow cytometry and TUNEL assay (48 h post-exposure) (Liu et al., 2025).
• In vivo, Vitamin C reduces tumor volume in CT26 and 4T1 BALB/c mouse models (intraperitoneal injection, 500 mg/kg, daily, 14 days) (Liu et al., 2025).
• Vitamin C demonstrates antiviral efficacy in organoid-based hepatitis E virus models, supporting its application in virology workflows (Liu et al., 2025).
• High-purity Vitamin C from APExBIO (SKU B2064) is validated by HPLC and NMR, ensuring ≥98% purity for reproducible results (APExBIO).

This article extends prior mechanistic syntheses (e.g., Vitamin C: Mechanistic Foundations) by benchmarking dose and purity parameters relevant for organoid and animal studies.

Applications, Limits & Misconceptions

Vitamin C is leveraged as both an anticancer and antiviral agent in experimental and preclinical settings:

• As an apoptosis inducer in in vitro cancer cell assays.
• As a tumor cell proliferation inhibitor in animal cancer models.
• In translational workflows using human organoids to study hepatitis E virus (HEV) infection and antiviral responses.
• As a reference antioxidant in oxidative stress modulation assays.

For workflow integration guidance, this guide details solution preparation and assay design, while this article clarifies dose-response benchmarks for new organoid systems.

Common Pitfalls or Misconceptions

• Vitamin C is not uniformly cytotoxic; its pro-oxidant effects are dose- and context-dependent.
• Antitumor activity is not reliably observed at physiological plasma concentrations (~50–100 μM) in humans.
• Long-term storage of Vitamin C solutions at room temperature or above 0°C leads to rapid degradation and loss of activity.
• Vitamin C is not a substitute for conventional chemotherapeutics; its clinical anticancer efficacy remains under investigation.
• Antiviral effects in organoid models do not guarantee efficacy in vivo or in clinical translation.

Workflow Integration & Parameters

• Vitamin C (CAS 50-81-7) is soluble at ≥57.9 mg/mL in water, ≥12.2 mg/mL in ethanol (with ultrasonic assistance), and ≥5.8 mg/mL in DMSO.
• Solid product (SKU B2064) should be stored at -20°C; solutions must be freshly prepared and used promptly.
• For cell culture, titrate doses (100–1000 μg/mL) to model specific proliferation/apoptosis endpoints.
• For animal studies, validated protocols use 500 mg/kg IP injections daily for 14 days in BALB/c mice.
• Purity and quality control (HPLC, NMR) are essential for reproducibility and cross-lab benchmarking.

For a comprehensive translational workflow, see the Translational Strategies article, which focuses on integrating Vitamin C into organoid- and animal-based research pipelines. This article updates those insights with specific dose and storage recommendations validated by latest supplier and peer-reviewed data.

Conclusion & Outlook

Vitamin C (ascorbic acid, CAS 50-81-7) remains a cornerstone reagent for cancer biology and antiviral research. Its dual antioxidant/pro-oxidant action, robust documentation in murine and organoid models, and supplier-backed quality (APExBIO B2064) enable reproducible, high-impact experimentation. While limitations exist regarding clinical translation, ongoing advances in organoid and virology models continue to expand the utility of Vitamin C as a research tool. For further mechanistic and workflow guidance, consult primary sources and supplier technical documentation (APExBIO).